Biolife Solutions (BLFS) Accumulated Expenses (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Accumulated Expenses data on file, last reported at $7.6 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 7.77% year-over-year to $7.6 million in Q1 2026; TTM through Mar 2026 was $7.6 million, a 7.77% decrease from a year earlier, with the FY2025 full-year figure at $12.0 million, down 1.23% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $7.6 million, down from $12.0 million in the prior quarter.
• Over the last five years, Accumulated Expenses for BLFS reached as high as $12.1 million in Q4 2024 and fell as low as $5.3 million in Q1 2023.
• Historically, Accumulated Expenses has averaged $8.8 million across 5 years, with a median of $8.6 million in 2023.
• Across the five-year window, Accumulated Expenses soared 1984.52% in 2022 and dropped 21.19% in 2023, its largest moves.
• Year by year, Accumulated Expenses stood at $9.8 million in 2022, then decreased by 6.76% to $9.1 million in 2023, then jumped by 32.91% to $12.1 million in 2024, then fell by 1.23% to $12.0 million in 2025, then plunged by 36.74% to $7.6 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $7.6 million in Q1 2026, $12.0 million in Q4 2025, and $10.9 million in Q3 2025.